Outcome of Short Period and Intermittent Imatinib-Phased Chemotherapy（Northern Italy Leukemia Group Protocol 09/00） as Therapy for Ph<sup>+</sup> ALL

DU  Xin; LING  Wei

doi:10.3969/j.issn.1671-5144.2011.05.013

DU Xin, LING Wei. Outcome of Short Period and Intermittent Imatinib-Phased Chemotherapy（Northern Italy Leukemia Group Protocol 09/00） as Therapy for Ph+ ALL[J]. Journal of Evidence-Based Medicine, 2011, 11(5): 270-272. DOI: 10.3969/j.issn.1671-5144.2011.05.013

Citation:

DU Xin, LING Wei. Outcome of Short Period and Intermittent Imatinib-Phased Chemotherapy（Northern Italy Leukemia Group Protocol 09/00） as Therapy for Ph+ ALL[J]. Journal of Evidence-Based Medicine, 2011, 11(5): 270-272. DOI: 10.3969/j.issn.1671-5144.2011.05.013

Citation:

DU Xin, LING Wei. Outcome of Short Period and Intermittent Imatinib-Phased Chemotherapy（Northern Italy Leukemia Group Protocol 09/00） as Therapy for Ph+ ALL[J]. Journal of Evidence-Based Medicine, 2011, 11(5): 270-272. DOI: 10.3969/j.issn.1671-5144.2011.05.013

Outcome of Short Period and Intermittent Imatinib-Phased Chemotherapy（Northern Italy Leukemia Group Protocol 09/00） as Therapy for Ph⁺ ALL

DU Xin,
LING Wei

Graphical Abstract

Abstract

FullText(HTML)

References (6)

Outcome of Short Period and Intermittent Imatinib-Phased Chemotherapy（Northern Italy Leukemia Group Protocol 09/00） as Therapy for Ph+ ALL

Catalog

Export File

Citation

Format

Content

Outcome of Short Period and Intermittent Imatinib-Phased Chemotherapy（Northern Italy Leukemia Group Protocol 09/00） as Therapy for Ph⁺ ALL